GAS5 and metabolic dysfunction-associated steatotic liver disease: GAS5 depletion reduced lipid accumulation in the mice (Figure 2(c)) and reversed the elevated NAFLD activity score in the HFD mice (P < 0.05) (Figure 2(d)).